Breast Reconstruction
1
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
GC BiopharmaKorea - Yongin
1 programPERLE Sterile Smooth Opaque gel filled mammary implantsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
2030
2031
AbbVieARTIA Reconstructive Tissue Matrix
GC BiopharmaPERLE Sterile Smooth Opaque gel filled mammary implants
Clinical Trials (2)
Total enrollment: 783 patients across 2 trials
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
Start: Nov 2024Est. completion: Dec 2029783 patients
Phase 3Recruiting
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
Start: Jun 2024Est. completion: Sep 2038
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 783 patients
2 companies competing in this space